676129-92-3
676129-92-3
Chemical Structure
Devaleryl Valsartan Impurity
- CAS No.: 676129-92-3
- Formula:C19H21N5O2
- Molecular Weight:351.40
IUPAC Name: ((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-L-valine
InChIKey: NSXSCTCKWRSTHJ-KRWDZBQOSA-N
SMILES: CC(C)[C@@H](C(O)=O)NCC1=CC=C(C2=CC=CC=C2C3=NNN=N3)C=C1
Biological Activity: Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Devaleryl Valsartan Impurity | 99.98% | Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Devaleryl Valsartan Impurity (Standard) | ≥98% | Devaleryl Valsartan Impurity (Standard) is the analytical standard of Devaleryl Valsartan Impurity (HY-131280). This product is intended for research and analytical applications. Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Irbesartan impurity 3 | Irbesartan impurity 3 is an impurity of Irbesartan. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Abitesartan | Abitesartan is an active compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-(4'-Methyl-[1,1'-biphenyl]-2-yl)-1H-tetrazole (Standard) | ≥98% | Losartan impurity E (Standard) is the analytical standard of Losartan impurity E. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Valsartan Ethyl Ester | 99.70% | Valsartan Ethyl Ester is an impurity of Valsartan. Valsartan is an angiotensin II receptor antagonist for the treatment of high blood pressure and heart failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Valsartan (Standard) | 99.95% | Valsartan (Standard) is the analytical standard of Valsartan. This product is intended for research and analytical applications. Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Valsartan-d3 | 94.36% | Valsartan-d3 is the deuterium labeled Valsartan. Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Valsartan | D-Valsartan is an impurity of Valsartan (HY-18204). Valsartan is an angiotensin II (angiotensin II) receptor antagonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Valsartan methyl ester (Standard) | ≥98% | Valsartan (CGP 48933) methyl ester (Standard) is the analytical standard of Valsartan methyl ester (HY-W414915). This product is intended for research and analytical applications. Valsartan methyl ester is the methyl ester derivative of Valsartan (HY-18204). Valsartan is a selective angiotensin II type 1 (AT1) receptor blocker (ARB) with potent antihypertensive and cardioprotective effects. Valsartan competitively binds to AT1 receptors, inhibiting the binding of angiotensin II to AT1 receptors, thereby blocking angiotensin II-mediated vasoconstriction, sodium retention, and myocardial hypertrophy signaling pathways. Valsartan reduces systolic blood pressure in L-NAME-induced hypertensive rats. Valsartan can be used for the study and treatment of arterial hypertension, hypertensive heart disease, and heart failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Hydroxy valsartan | 4-Hydroxy valsartan is a metabolite of Valsartan (HY-18204). 4-Hydroxy valsartan regulates the expression of platelet surface receptors and inhibits conventional plasma or whole blood collagen induced platelet aggregation. 4-Hydroxy valsartan has antiplatelet activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine (Standard) | 99.38% | (S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine (Standard) is the analytical standard of (S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
